Dashboard
Manage Tickers

ALLK


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

allakos-q2-eps-030-beats-034-estimate
Allakos Q2 EPS $(0.30) Beats $(0.34) Estimate
08/07/2024 20:26:39

Allakos (NASDAQ:ALLK) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.34) by 11...

jefferies-maintains-hold-on-allakos-lowers-price-target-to-1
Jefferies Maintains Hold on Allakos, Lower...
07/18/2024 13:15:57

Jefferies analyst Kevin Strang maintains Allakos (NASDAQ:ALLK) with a Hold and lowers the price target from $1.5 to $1.

jmp-securities-reiterates-market-outperform-on-allakos-maintains-3-price-target
JMP Securities Reiterates Market Outperfor...
06/26/2024 16:01:04

JMP Securities analyst Jonathan Wolleben reiterates Allakos (NASDAQ:ALLK) with a Market Outperform and maintains $3 price ta...

allakos-announces-phase-1-results-for-ak006-achieved-serum-concentrations-showing-inhibitory-activity-in-preclinical-experiments-skin-biopsies-show-high-receptor-occupancy-ak006-was-well-tolerated-with-a-favorable-safety-profile
Allakos Announces Phase 1 Results for AK00...
06/25/2024 20:02:39

cantor-fitzgerald-reiterates-neutral-on-allakos
Cantor Fitzgerald Reiterates Neutral on Al...
06/20/2024 17:20:23

Cantor Fitzgerald analyst Jennifer Kim reiterates Allakos (NASDAQ:ALLK) with a Neutral.

allakos-says-first-patient-has-been-dosed-in-phase-1-trial-of-ak006-in-chronic-spontaneous-urticaria
Allakos Says First Patient Has Been Dosed ...
05/28/2024 11:06:31

allakos-q1-2024-gaap-eps-081-misses-044-estimate
Allakos Q1 2024 GAAP EPS $(0.81) Misses $(...
05/09/2024 20:54:22

Allakos (NASDAQ:ALLK) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.44) by ...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
05/01/2024 20:31:24

allakos-q4-eps-071-misses-047-estimate
Allakos Q4 EPS $(0.71) Misses $(0.47) Esti...
03/14/2024 20:05:06

Allakos (NASDAQ:ALLK) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of $(0.47) by ...

allakos-announced-a-poster-presentation-at-the-2024-american-academy-of-allergy-asthma--immunology-annual-meeting-the-poster-highlights-preclinical-data-detailing-ak006s-mechanism-of-action-and-ability-to-reduce-mrgprx2-induced-skin-inflammation
Allakos Announced A Poster Presentation At...
02/26/2024 12:18:09

Atopic dermatitis and prurigo nodularis skin lesions show evidence of MRGPRX2 mast cell activation and activated macrophages ...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
02/14/2024 13:05:52

allakos-announced-the-publication-of-new-scientific-results-in-allergy-the-preclinical-research-found-that-ak006-agonist-siglec-6-antibody-impacts-mast-cell-function-by-interacting-with-multiple-activating-receptors-and-key-signaling-molecules
Allakos Announced The Publication Of New S...
02/12/2024 12:32:26

jmp-securities-maintains-market-outperform-on-allakos-lowers-price-target-to-3
JMP Securities Maintains Market Outperform...
01/17/2024 19:16:22

JMP Securities analyst Jonathan Wolleben maintains Allakos (NASDAQ:ALLK) with a Market Outperform and lowers the price targe...

netflix-to-rally-over-13-here-are-10-top-analyst-forecasts-for-wednesday
Netflix To Rally Over 13%? Here Are 10 Top...
01/17/2024 13:19:50

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
01/17/2024 13:05:58

barclays-maintains-underweight-on-allakos-lowers-price-target-to-1
Barclays Maintains Underweight on Allakos,...
01/17/2024 11:17:10

Barclays analyst Carter Gould maintains Allakos (NASDAQ:ALLK) with a Underweight and lowers the price target from $1.5 to $1.

jefferies-downgrades-allakos-to-hold-lowers-price-target-to-15
Jefferies Downgrades Allakos to Hold, Lowe...
01/17/2024 10:56:00

Jefferies analyst Kevin Strang downgrades Allakos (NASDAQ:ALLK) from Buy to Hold and lowers the price target from $6 to $1.5.

gold-down-1-pnc-financial-posts-upbeat-earnings
Gold Down 1%; PNC Financial Posts Upbeat E...
01/16/2024 19:14:27

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 350 points on Tuesday. The Dow tra...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
01/16/2024 17:31:05

crude-oil-edges-lower-morgan-stanley-posts-upbeat-revenue
Crude Oil Edges Lower; Morgan Stanley Post...
01/16/2024 16:53:08

U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling more than 150 points on Tuesday. The ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION